Journal for ImmunoTherapy of Cancer (Nov 2023)
1150 DM005, an EGFR × MET bispecific antibody-drug conjugate, showed robust anti-tumor activity in PDX models
- Jun Li,
- Hao Li,
- Yi Yang,
- Yujie Liu,
- Baihong Liu,
- W Frank An,
- Chaoshe Guo,
- Chengzhang Shang,
- Yuelei Shen,
- Gao An,
- Yanfei Han,
- Zhuolin Li,
- Zhenyan Han,
- Wenjuan Dai,
- Zixu Cui,
- Wanjun Hao
Affiliations
- Jun Li
- Department of Pharmacy, Nanjing First Hospital, Nangjing, Jiangsu, China
- Hao Li
- Department of Neurosurgery, Sichuan University West China Hospital, Chengdu, China
- Yi Yang
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Yujie Liu
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Baihong Liu
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- W Frank An
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Chaoshe Guo
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Chengzhang Shang
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Yuelei Shen
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Gao An
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Yanfei Han
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Zhuolin Li
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Zhenyan Han
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Wenjuan Dai
- 2Doma Biopharmaceutical (Suzhou) Co., Ltd., Suzhou, Jiangsu, China
- Zixu Cui
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- Wanjun Hao
- 1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.1150
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
